Literature DB >> 10611545

Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels.

L Weiser1, M Bhargava, E Attia, P A Torzilli.   

Abstract

In this in vitro study, cell proliferation, viability, and morphology; proteoglycan (PG) synthesis; and gel contraction were assessed over a 15-day period (on days 3, 6, 9, 12, and 15) for mature bovine chondrocytes cultured in collagen gels. The environment within the gel was varied by changing the concentration of fetal bovine serum (1% and 10%) and platelet-derived growth factor-BB (PDGF; 0, 10, 50, 100 ng/ml) within the gel and incubation media. Our results showed that the amount of serum or PDGF added to the gels had no effect on cell viability, with >95% of cells remaining alive throughout the experiment. There was a significant increase in cell number over time in all groups, with a higher rate of cell proliferation in gels containing 10% serum and higher concentrations of PDGF. In addition, the amount of serum significantly affected gel contraction with or without PDGF. Gels containing 10% serum contracted on day 10-12, while none of the gels containing 1% serum contracted over the course of the experiment. The PG content within each gel increased with incubation time only for the gels containing 1% serum, and 10 or 100 ng/ml of PDGF. However, on a per cell basis, there was no change in the PG content with time when only serum was used and a significant decrease in the rate of PG production with the addition of PDGF (9.1-27.8 pgPG/cell/day). Cell morphology was also affected by PDGF, with the cells becoming more spindle shaped. Cell alignment within the gels appeared to be most affected by gel contraction. Collagen gels can act as cell carriers for the purpose of tissue engineering. These gels provide a three-dimensional environment in which chondrocytes can proliferate and produce matrix. We have shown how this environment can be controlled to affect gel contraction, rates of cell growth and PG production, and cellular morphology while maintaining cell viability. This information will be useful in determining the conditions in which chondrocytes can be grown within collagen gels and combined with cytokines to create an ideal tissue construct.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611545     DOI: 10.1089/ten.1999.5.533

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  11 in total

1.  Prediction of growth factor effects on engineered cartilage composition using deterministic and stochastic modeling.

Authors:  Asit K Saha; Jagannath Mazumdar; Sean S Kohles
Journal:  Ann Biomed Eng       Date:  2004-06       Impact factor: 3.934

2.  Platelet gel for the treatment of traumatic loss of finger substance.

Authors:  Riccardo Balbo; Ilaria Avonto; Dario Marenchino; Laura Maddalena; Giuseppe Menardi; Gianmichele Peano
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

3.  The role of tissue engineering in articular cartilage repair and regeneration.

Authors:  Lijie Zhang; Jerry Hu; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2009

4.  Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients.

Authors:  Raffaele Serra; Gianluca Buffone; Andrea Dominijanni; Vincenzo Molinari; Rossella Montemurro; Stefano de Franciscis
Journal:  Int Wound J       Date:  2013-02-24       Impact factor: 3.315

5.  Platelet gel in oral and maxillofacial surgery: a single-centre experience.

Authors:  Andrea Dominijanni; Maria Giulia Cristofaro; Adalgisa Brescia; Mario Giudice
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

6.  Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes.

Authors:  C Kaps; A Loch; A Haisch; H Smolian; G R Burmester; T Häupl; M Sittinger
Journal:  Med Biol Eng Comput       Date:  2002-07       Impact factor: 2.602

7.  Characterization of total and active matrix metalloproteinases-1, -3, and -13 synthesized and secreted by anterior cruciate ligament fibroblasts in three-dimensional collagen gels.

Authors:  Erik Attia; Krista Bohnert; Haydee Brown; Madhu Bhargava; Jo A Hannafin
Journal:  Tissue Eng Part A       Date:  2013-10-25       Impact factor: 3.845

8.  The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.

Authors:  K Vandyke; S Fitter; A C W Zannettino
Journal:  Blood Cancer J       Date:  2011-02-04       Impact factor: 11.037

9.  Effect of Combined Leukocyte-Poor Platelet-Rich Plasma and Hyaluronic Acid on Bone Marrow-Derived Mesenchymal Stem Cell and Chondrocyte Metabolism.

Authors:  Alexander M Satin; Jolanta B Norelli; Nicholas A Sgaglione; Daniel A Grande
Journal:  Cartilage       Date:  2019-07-07       Impact factor: 3.117

10.  AIMP1 downregulation restores chondrogenic characteristics of dedifferentiated/degenerated chondrocytes by enhancing TGF-β signal.

Authors:  J Ahn; H Kumar; B-H Cha; S Park; Y Arai; I Han; S G Park; S-H Lee
Journal:  Cell Death Dis       Date:  2016-02-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.